LETBEV

Serial Number 99236970
661

Registration Progress

Application Filed
Jun 16, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Jan 23, 2026 75 days

Trademark Image

LETBEV

Basic Information

Serial Number
99236970
Filing Date
June 16, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Nov 4, 2025
Application
Pending
Classes
005

Rights Holder

Pfizer Inc.

03
Address
66 Hudson Boulevard East
New York, NY 10001-2192

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Andrea Christensen

USPTO Deadlines

Next Deadline
75 days remaining
Non-Final Action E-Mailed
Due Date
January 23, 2026
Extension Available
Until April 23, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

14 events
Date Code Type Description Documents
Nov 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 4, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 23, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 22, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 17, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 17, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 17, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 17, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 16, 2025 NWAP I NEW APPLICATION ENTERED Loading...
Jun 16, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, cachexia, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use

Classification

International Classes
005